HOME >> BIOLOGY >> NEWS
Managing For Deer, Moose, Elk, Wolves -- And People

The latest edition of Ecological Applications Examines Management Practices in the U.S. National Park Service

The National Park Service incorporates some of the most impressive and important natural systems in the United States of America. Filled with awe-inspiring views, unique natural wonders, and multitudes of native flora and fauna, the parks many seem to many like museums of nature. And to the general public, the NPS staff may seem like a team of curators, charged with preserving a view of what our country looked like before the arrival of Europeans.

But the true role of the NPS is much more complicated and much less static. In the eighty three years since the U.S. Congress established the National Park system, the land management practices of the parks have evolved and changed to meet both public approval and logistic feasibility. In addition, the study of ecological systems in and around the parks have revealed new insights into what may or may not be ecologically appropriate decisions regarding park management.

The February edition of Ecological Applications presents a special feature on wildlife management in the US National Park system. Included are three case studies which were presented during a workshop at the Ecological Society of America's 1996 Annual Meeting.

Of Elephants and Blind Men: Deer Management in the U.S. National Parks by William Porter of the State University of New York at Syracuse and Brian Underwood of the Biological Resources Division, United States Geological Survey, examines the controversial issue of white-tailed deer population surges in eastern National Parks. "Like blind men touching different parts of an elephant and disagreeing about its form," the authors write, "those engaged in the debate about deer management in parks are viewing different parts of the ecological system. None has seen the entire system, and consequently there is neither common agreement on the nature of the pro
'"/>

Contact: Alison Gillespie
alison@esa.org
202-416-6181
Ecological Society of America
24-Feb-1999


Page: 1 2 3 4

Related biology news :

1. Managing occupational exposures to potential bioterrorist agents
2. At the waters edge -- Managing riparian forests
3. Wolves are rebalancing Yellowstone ecosystem
4. Wolves decline, moose increase
5. Wolves in Yellowstone may aid aspen recovery
6. Isle Royale Wolves Bounce Back
7. People with undetermined muscle/bone pain tend to be severely vitamin D deficient
8. Peoples household dynamics crucial to biodiversity
9. People from distant lands have strikingly similar genetic traits, study reveals
10. People linked to new sea otter diseases
11. People and fire at Floridas wildland-urban interface

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Managing For Deer Moose Elk Wolves And People

(Date:10/29/2014)... who lose their hair as a consequence of chemotherapy ... improve the scalp cooling technology that prevents hair loss. ... being pioneered by global scalp cooling manufacturing company, Paxman ... biology department of the University of Huddersfield. , The ... who has a background in the pharmacology of cancer ...
(Date:10/29/2014)... research presented at the Society for Integrative Oncology ... for the first time that it is possible ... readily available nutritional supplement, AHCC. ... Smith, Pharm.D., associate professor in the Department of ... of Texas Health Science Center at Houston (UTHealth) ...
(Date:10/29/2014)... Many factors, both genetic and environmental, have been ... of schizophrenia. Some, such as a family history ... infection with Toxoplasma gondii , a parasite ... are still viewed with skepticism. , A new ... and epidemiology at the University of Pennsylvania,s School ...
Breaking Biology News(10 mins):New technology on the way to aid cancer suffers who lose their hair after chemotherapy 2HPV infections in women eradicated by AHCC, Japanese mushroom extract 2Penn vet professor investigates parasite-schizophrenia connection 2Penn vet professor investigates parasite-schizophrenia connection 3
(Date:10/27/2014)... and TORONTO , Oct. ... www.generex.com ) (OTCQB: GNBT) today announced two presentations ... triggered by its novel proprietary cancer immunotherapeutic AE37 ... breast cancer patients. The AE37 cancer vaccine is ... Express, Inc. ( www.antigenexpress.com ). The presentations are ...
(Date:10/27/2014)... Orlando, Florida (PRWEB) October 27, 2014 ... aims at reducing and eliminating several types of ... have not been achieved in over 30 years ... of Noah's Light Foundation, proves that one mom's ... was diagnosed just before Halloween trick-or-treating, and it’s ...
(Date:10/27/2014)... October 27, 2014 Investor-Edge has ... (NASDAQ: NBIX ), Insmed Inc. (NASDAQ: ... BCRX ), Dyax Corporation (NASDAQ: DYAX ), ... five companies can be accessed at: http://investor-edge.com/register ... Composite ended at 4,483.72, up 0.69%, the Dow Jones ...
(Date:10/25/2014)... 2014 ViaDerma, Inc ... devoted to bringing new products to market, is ... ViaDerma has developed an innovative, patent-pending dual carrier ... transfer of pharmaceutical active ingredients to penetrate the ... localized therapy. The transdermal delivery method also overcomes ...
Breaking Biology Technology:Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 2Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 3Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 4FDA Approves Breakthrough in Pediatric Brain Cancer - First in 30 Years 2FDA Approves Breakthrough in Pediatric Brain Cancer - First in 30 Years 3Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 2Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 3Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 4Pre-market Equity Watch on Biotech Industry - Neurocrine Biosciences, Insmed, BioCryst Pharma, Dyax, and Oncothyreon 5ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 2ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015 3
Cached News: